Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Dec;44(8):1716-1720.
doi: 10.1007/s00246-023-03259-x. Epub 2023 Aug 11.

N-Terminal Pro-B-Type Natriuretic Peptide as a Marker of Severity of Heart Failure in Children with Congenital Heart Diseases

Ritabrata Roy Chowdhury  1 , Satnam Kaur  1 , Rani Gera  2
Affiliations
Observational Study

N-Terminal Pro-B-Type Natriuretic Peptide as a Marker of Severity of Heart Failure in Children with Congenital Heart Diseases

Ritabrata Roy Chowdhury et al. Pediatr Cardiol. 2023 Dec.

Abstract

N-terminal pro-B-type natriuretic peptide (NT-proBNP) has been used as a tool for diagnosis, severity assessment and prognostication of congestive heart failure (CHF) in adults, with specific cut off values for diagnosis and denoting points of intervention. However, there is scarcity of paediatric literature regarding role of NT-proBNP as a marker of heart failure severity and prognostication. So, this study was done to assess the utility of NT-proBNP as a marker of severity of heart failure in children with congenital heart diseases. Single centre, prospective observational study. Children (1 month to 5 years), with congenital heart disease, admitted in the paediatric wards with varying severity of CHF were enrolled. Heart failure severity grading was done according to Laer modification of Ross Classification at the time of presentation to hospital and children were classified as having no/grade I CHF (score: 0-2); mild/grade II CHF (score 3-6); moderate/grade III CHF (score 7-9) or severe/grade IV CHF (score 10-12). NT-proBNP levels were measured within 24 h of admission. Eighty children with congenital heart disease were enrolled in this study. As per modified Ross Classification, 11 had grade I/No heart failure (13.7%), 32 children had grade II/mild heart failure (40%), 36 had grade III/moderate heart failure (45%) and only 1 had grade IV/severe heart failure (1.25%). The median NT-proBNP levels (IQR) in the above mentioned grades of heart failure were found to be 321.11 (211.1-411.78 pg/ml), 750.62 (474.62-995.2 pg/ml), 4159.61 (1440.59-11,857 pg/ml) and 11,320.34 pg/ml, respectively. Seven children (8.75%) expired. Median NT-proBNP value in seven children who died was significantly higher than those who survived [median (IQR): 11,681.01 pg/ml (10,092.72-14,754 pg/ml) vs 839.4 pg/ml (456.67-3288.09 pg/ml), p value < 0.001]. NT-proBNP level of 520.2 pg/ml predicted grade II (mild heart failure) or more severe grades of heart failure with Sensitivity, Specificity, Negative Predictive Value and Positive Predictive Value of 83%, 91%, 57.1% and 98%, respectively. NT-proBNP levels increase progressively with increasing severity of CHF and can be used as a marker of severity of heart failure in children with congenital heart disease presenting with CHF.

Keywords: Congenital heart disease; Congestive heart failure; Modified Ross Classification; NT-proBNP.

PubMed Disclaimer

References

    1. van der Linde D, Konings E, Slager M, Witsenburg M, Helbing W, Takkenberg P et al (2011) Birth prevalence of congenital heart disease worldwide. J Am Coll Cardiol 58(21):2241–2247 - DOI - PubMed
    1. Sahin M, Portakal O, Karagoz T, Hasçelik G, Ozkutlu S (2010) Diagnostic performance of BNP and NT-ProBNP measurements in children with heart failure based on congenital heart defects and cardiomyopathies. Clin Biochem 43:1278–81 - DOI - PubMed
    1. Mir T, Marohn S, Laer S, Eiselt M, Grollmus O, Weil J (2002) Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 110(6):76–82 - DOI
    1. Lin C, Zeng X, Zhang J, Meng X (2014) Determining the optimal cut off values of plasma N-terminal pro–B-type natriuretic peptide levels for the diagnosis of heart failure in children of age up to 14 years. J Card Fail 20(3):168–173 - DOI - PubMed
    1. Maher K, Reed H, Cuadrado A, Simsic J, Mahle WT, Deguzman M et al (2008) B-type natriuretic peptide in the emergency diagnosis of critical heart disease in children. Paediatrics 121(6):1484–1488 - DOI

Publication types

LinkOut - more resources